Cincinnati Financial Corp’s Pfizer PFE Stock Holding History

Cincinnati Financial Corp’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-486,876	Closed	-$12.1M	–	57
2025 Q4	$12.1M	Sell	486,876 -92,224	-16%	-$2.33M	0.24%	46
2025 Q3	$14.8M	Hold	579,100	–	–	0.29%	45
2025 Q2	$14M	Hold	579,100	–	–	0.3%	44
2025 Q1	$14.7M	Hold	579,100	–	–	0.33%	42
2024 Q4	$15.4M	Hold	579,100	–	–	0.34%	40
2024 Q3	$16.8M	Hold	579,100	–	–	0.36%	41
2024 Q2	$16.2M	Hold	579,100	–	–	0.35%	41
2024 Q1	$16.1M	Hold	579,100	–	–	0.35%	41
2023 Q4	$16.7M	Hold	579,100	–	–	0.37%	43
2023 Q3	$19.2M	Hold	579,100	–	–	0.46%	43
2023 Q2	$21.2M	Hold	579,100	–	–	0.49%	40
2023 Q1	$23.6M	Hold	579,100	–	–	0.57%	39
2022 Q4	$29.7M	Hold	579,100	–	–	0.75%	36
2022 Q3	$25.3M	Hold	579,100	–	–	0.69%	35
2022 Q2	$30.4M	Hold	579,100	–	–	0.77%	35
2022 Q1	$30M	Hold	579,100	–	–	0.66%	39
2021 Q4	$34.2M	Hold	579,100	–	–	0.72%	37
2021 Q3	$24.9M	Hold	579,100	–	–	0.61%	40
2021 Q2	$22.7M	Hold	579,100	–	–	0.55%	43
2021 Q1	$21M	Hold	579,100	–	–	0.54%	43
2020 Q4	$21.3M	Sell	579,100 -31,271	-5%	-$1.15M	0.58%	40
2020 Q3	$21.3M	Buy	610,371 +162,316	+36%	+$5.69M	0.65%	41
2020 Q2	$13.9M	Hold	448,055	–	–	0.47%	44
2020 Q1	$13.9M	Hold	448,055	–	–	0.56%	44
2019 Q4	$16.7M	Hold	448,055	–	–	0.54%	42
2019 Q3	$15.3M	Hold	448,055	–	–	0.55%	43
2019 Q2	$18.4M	Buy	448,055 +32,779	+8%	+$1.3M	0.67%	38
2019 Q1	$16.7M	Hold	415,276	–	–	0.68%	38
2018 Q4	$17.2M	Hold	415,276	–	–	0.77%	38
2018 Q3	$17.4M	Hold	415,276	–	–	0.68%	39
2018 Q2	$14.3M	Hold	415,276	–	–	0.61%	38
2018 Q1	$14M	Hold	415,276	–	–	0.61%	38
2017 Q4	$14.3M	Hold	415,276	–	–	0.63%	36
2017 Q3	$14.1M	Hold	415,276	–	–	0.64%	37
2017 Q2	$13.2M	Hold	415,276	–	–	0.63%	38
2017 Q1	$13.5M	Hold	415,276	–	–	0.66%	35
2016 Q4	$12.8M	Hold	415,276	–	–	0.7%	35
2016 Q3	$13.3M	Hold	415,276	–	–	0.74%	35
2016 Q2	$13.9M	Hold	415,276	–	–	0.78%	36
2016 Q1	$11.7M	Hold	415,276	–	–	0.69%	38
2015 Q4	$12.7M	Hold	415,276	–	–	0.81%	33
2015 Q3	$12.4M	Hold	415,276	–	–	0.8%	35
2015 Q2	$13.2M	Hold	415,276	–	–	0.83%	35
2015 Q1	$13.7M	Hold	415,276	–	–	0.83%	34
2014 Q4	$12.3M	Hold	415,276	–	–	0.75%	37
2014 Q3	$11.7M	Hold	415,276	–	–	0.77%	35
2014 Q2	$11.7M	Hold	415,276	–	–	0.79%	35
2014 Q1	$12.7M	Hold	415,276	–	–	0.92%	33
2013 Q4	$12.1M	Hold	415,276	–	–	0.89%	33
2013 Q3	$11.3M	Hold	415,276	–	–	0.9%	33
2013 Q2	$11M	Buy	+415,276	New	+$11.5M	0.92%	32

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Cincinnati Financial Corp's PFE Position: Q1 2026 in Review

Cincinnati Financial Corp sold out of Pfizer (PFE) in Q1 2026, closing a stake of 486,876 shares — an estimated $12.1M sold.

Cincinnati Financial Corp first reported a position in PFE in Q2 2013 and held it in 51 quarters. The position peaked at $34.2M in Q4 2021. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Cincinnati Financial Corp reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
Cincinnati Financial Corp sold 486,876 Pfizer shares in Q1 2026, an estimated $12.1M.
Cincinnati Financial Corp first reported a position in Pfizer in Q2 2013 and held it in 51 quarters.
Cincinnati Financial Corp's Pfizer position peaked at $34.2M in Q4 2021.
2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Cincinnati Financial Corp's 13F filing for Q1 2026, filed 11 May 2026.